CRISPR THERAPEUTICS AG (CRSP) Stock News

USA - NASDAQ:CRSP - CH0334081137 - Common Stock

72.32 USD

-1.65 (-2.23%)

Last: 10/21/2025, 8:06:50 PM

71.61 USD

-0.71 (-0.98%)

After Hours: 10/21/2025, 8:06:50 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

CRSP Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Zacks Investment Research - Mentions: REGN BEAM NTLA

Can NTLA's In Vivo Pipeline Aid Long-Term Growth Amid Competition?

2 days ago - By: Zacks Investment Research

Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know

5 days ago - By: The Motley Fool - Mentions: AAPL AMZN VRTX GOOG ...

2 Soaring Cathie Wood Stocks to Buy and Hold

6 days ago - By: The Motley Fool

New to Growth Stocks? Here's 1 Every Investor Should Have on Their Radar.

8 days ago - By: Zacks Investment Research

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

12 days ago - By: CRISPR Therapeutics AG

CRISPR Therapeutics Presents New Preclinical Data for CTX460™ Demonstrating In Vivo Gene Correction of Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase™ Editing Platform

13 days ago - By: Benzinga - Mentions: AMGN ALC PFE SMMT ...

10 Health Care Stocks Whale Activity In Today's Session

a month ago - By: Benzinga

How Is The Market Feeling About CRISPR Therapeutics?

21 days ago - By: CRISPR Therapeutics AG

CRISPR Therapeutics to Present Preclinical Data on Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Gene Editing Technology at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress

a month ago - By: CRISPR Therapeutics AG

CRISPR Therapeutics and Sirius Therapeutics Announce First Patient Dosed in Phase 2 Trial of SRSD107 for Thromboembolic Disorders in Europe

a month ago - By: Zacks Investment Research

CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know

a month ago - By: Zacks Investment Research

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

a month ago - By: CRISPR Therapeutics AG

CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025

2 months ago - By: Zacks Investment Research - Mentions: ILMN

CRISPR Therapeutics (CRSP) Down 5.3% Since Last Earnings Report: Can It Rebound?

2 months ago - By: Zacks Investment Research - Mentions: VRTX BEAM NTLA

Can CRSP's In Vivo Pipeline Aid Long-Term Growth Beyond Casgevy?

2 months ago - By: Zacks Investment Research - Mentions: VRTX BEAM

CRSP vs. BEAM: Which Gene Editing Stock Holds More Potential Right Now?

2 months ago - By: Zacks Investment Research - Mentions: VRTX BEAM NTLA

CRISPR Therapeutics Gains 41.4% in 3 Months: How to Play the Stock

2 months ago - By: Zacks Investment Research

Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know